⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL52133 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL21820004 | 0.98 | CYP2D6 (0.61) | — | |
| Ammonia Solution, Strong SCHEMBL28439739 | 0.98 | CYP2D6 (0.61) | — | |
| Glutamic Acid SCHEMBL7821241 | 0.89 | GRM8 (0.72) | — | |
| Alanine SCHEMBL29050844 | 0.89 | GABRP (0.54) | — | |
| Aspartic Acid SCHEMBL7823074 | 0.86 | GRM8 (0.55) | — | |
| SCHEMBL10530673 | 0.86 | ENPEP (0.52) | — | |
| SCHEMBL11453652 | 0.86 | ENPEP (0.52) | — | |
| SCHEMBL61065 | 0.80 | — | — | |
| SCHEMBL887143 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140309192-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC, | 2014-10-16 | — | — | US | claimed |
| EP-1512397-B1 | O-SUBSTITUTED HYDROXYARYL DERIVATIVES | INST MED MOLECULAR DESIGN INC (JP) | 2014-10-08 | — | — | EP | claimed |
| EP-2776407-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2014-09-17 | — | — | EP | claimed |
| WO-2013070657-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2013-05-16 | — | — | WO | claimed |
| US-20100113770-A1 | O-SUBSTITUTED HYDROXYARYL DERIVATIVES | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2010-05-06 | — | — | US | claimed |
| US-7604797-B2 | Administering to a burn an anticytokine or antiinflammatory agent and a pharmaceutically excipient; administering to a mammal having a burn injury:sodium monofluorophosphate and a dihydrofolate reductase inhibitor of aminopterin, methotrexate, pyramethamine, trimethoprim or derivatives | BIOMECHANISMS INC. (US) | 2009-10-20 | — | — | US | claimed |
| CN-114555127-A | Method for preparing polyglutamated antifolates and use of compositions thereof | L.E.A.F.控股集团公司 | 2022-05-27 | — | — | CN | disclosed |
| US-20140309192-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC, | 2014-10-16 | — | — | US | disclosed |
| EP-1512397-B1 | O-SUBSTITUTED HYDROXYARYL DERIVATIVES | INST MED MOLECULAR DESIGN INC (JP) | 2014-10-08 | — | — | EP | disclosed |
| EP-2776407-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2014-09-17 | — | — | EP | disclosed |
| WO-2013070657-A1 | MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2013-05-16 | — | — | WO | disclosed |
| EP-2429535-A2 | COMPOSITIONS AND METHODS FOR TREATING BURNS | Mindcake, LLC (US) | 2012-03-21 | — | — | EP | disclosed |
| WO-2010123759-A2 | COMPOSITIONS AND METHODS FOR TREATING BURNS | HICKS TERRY LEE (US) | 2010-10-28 | — | — | WO | disclosed |
| WO-2005087251-A1 | COMPOSITIONS AND METHODS FOR INHIBITING ABNORMAL CELL GROWTH | CLAWNOR, INC. (US) | 2005-09-22 | — | — | WO | disclosed |
| US-20050209150-A1 | Compositions and methods for inhibiting abnormal cell growth | CLAWNOR, INC. | 2005-09-22 | — | — | US | disclosed |
| WO-2005032470-A2 | COMPOSITIONS AND METHODS FOR TREATING BURNS | KOHI CORPORATION (US) | 2005-04-14 | — | — | WO | disclosed |
| EP-1512397-A1 | O-SUBSTITUTED HYDROXYARYL DERIVATIVES | Institute of Medicinal Molecular Design, Inc. (JP) | 2005-03-09 | — | — | EP | disclosed |
| US-4863903-A | RENIN ENZYME INHIBITORS, HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1989-09-05 | — | — | US | disclosed |
| US-4719288-A | HYPOTENSIVE | CIBA-GEIGY CORPORATION (US) | 1988-01-12 | — | — | US | disclosed |
| US-4613676-A | PEPTIDES | CIBA-GEIGY CORPORATION (US) | 1986-09-23 | — | — | US | disclosed |